Follow the 이엠텍 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 이엠텍 has logged 11 insider filings. Market capitalisation: €68.3bn. The latest transaction was disclosed on 26 August 2026 (Purchase). Among the most active insiders: 정승규. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
이엠텍 es una empresa que cotiza en el mercado XKRX, especializada en el sector de la salud y farmacéutico. Se centra en el desarrollo y la distribución de productos farmacéuticos y dispositivos médicos.